Community briefs: Cancer Drug Clinical Trial Begins at Norris Cotton – Valley News

Read article - An article reporting that research on a new antibody cancer drug spearheaded by Randolph Noellem, professor of microbiology and immunology, has begun human clinical trials. The drug, CI-8993, is an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody that is designed to target a molecule that keeps the immune system quiet against cancer.